Pentapeptide modified resin
US4258152A · kind A · utility
2Cited by
4References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 12, 1979 |
| Grant date | Mar 24, 1981 |
| Priority date | — |
| Expiry date | Jun 12, 1999 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are disclosed polypeptide compositions having the following amino acid sequence as the active site: EQU ARG-LYS-ASP-VAL-TYR These polypeptides have the capability of inducing the differentiation of T-lymphocytes but not of complement receptor (CR.sup.+) B-lymphocytes and thus are useful in a number of therapeutic areas. Also provided are derivatives of the pentapeptide, novel intermediate polypeptides, methods of manufacture of the peptides, therapeutic compositions, and methods for use of the compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.